1,008
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Determination and diagnostic value of CA9 mRNA in peripheral blood of patients with oral leukoplakia

, ORCID Icon, , , ORCID Icon, & show all
Pages 951-955 | Received 08 Mar 2018, Accepted 14 Apr 2018, Published online: 10 May 2018

References

  • Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000–2010. Cancer Epidemiol 2015;39:497–504.
  • Brouns E, Baart J, Karagozoglu K, et al. Malignant transformation of oral leukoplakia in a well‐defined cohort of 144 patients. Oral Dis 2014;20:e19–e24.
  • Warnakulasuriya S, Johnson NW, Van Der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36:575–80.
  • Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol 2003;39:770–80.
  • Schaaij-Visser TB, Bremmer JF, Braakhuis BJ, et al. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Oral Oncol 2010;46:123–7.
  • Amagasa T, Yamashiro M, Ishikawa H. Oral leukoplakia related to malignant transformation. Oral Sci Int 2006;3:45–55.
  • Liu W, Wang Y, Zhou H, et al. Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer 2010;10:685.
  • Di Meo A, Bartlett J, Cheng Y, et al. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Mol Cancer 2017;16:80.
  • de Martino M, Lucca I, Mbeutcha A, et al. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer. Eur Urol 2015;68:552–4.
  • Chia SK, Wykoff CC, Watson PH, et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 2001;19:3660–8.
  • Chen C, Chu J, Su W, et al. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1α, GLUT1, and CAIX. Virchows Archiv 2010;457:53–61.
  • Cheng F, Wang X, Zhong D, et al. Significance of detection of serum carbonic anhydrase IX in the diagnosis of lung cancer. Zhongguo Fei Ai Za Zhi 2015;18:29–33.
  • Ilie M, Mazure NM, Hofman V, et al. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer. Br J Cancer 2010;102:1627–35.
  • Pastorek J, Pastorekova S, Callebaut I, et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994;9:2877–88.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402–8.
  • Pérez-Sayáns M, Suárez-Peñaranda J, Torres-López M, et al. The use of CA-IX as a diagnostic method for oral leukoplakia. Biotech Histochem 2015;90:124–31.
  • Perez-Sayans M, Suarez-Penaranda J, Torres-Lopez M, et al. Expression of CA IX in dysplasia adjacent to surgical resection margins of oral squamous cell carcinoma. Biotech Histochem 2014;89:91–7.
  • Takacova M, Bartosova M, Skvarkova L, et al. Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma. Oncol Lett 2013;5:191–7.
  • Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.